Copyright
©The Author(s) 2025.
World J Diabetes. May 15, 2025; 16(5): 103447
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.103447
Published online May 15, 2025. doi: 10.4239/wjd.v16.i5.103447
Table 1 Comparison of three most commonly used surgical treatments
Jejunoileal side-to-side anastomosis | Roux-en-Y gastric bypass | sleeve gastrectomy | |
Targeting the crowd | It is mainly targeted at T2DM patients with normal or relatively high BMI and comorbidities | It is primarily targeted at T2DM patients with high BMI and comorbidities | It is primarily targeted at T2DM patients with high BMI and with or without comorbidities |
Effectiveness | Effectively alleviates T2DM and related comorbidities | Significant weight loss and effective reduction of T2DM and related comorbidities | The weight loss outcomes were substantial; however, the improvement in comorbidities was less pronounced compared to Roux-en-Y gastric bypass |
Safety | It may cause long-term nutrient absorption problems due to intestinal reconstruction, but there are few clinical studies and no obvious data support | Early complications include: Anastomotic leak, hemorrhage obstruction Venous thrombo-embolic disease. Infections: Late complications include: Internal herniation (most common). Stricture. Micronutrient deficiency. Hyperoxaluria. Gallstone formation. Dumping syndrome. Marginal ulcers. Gastrogastric fistula. Failed weight loss maintenance. Roux-en-Y Gastric Bypass has a higher mortality rate of about 0.2% than sleeve gastrectomy | The complication rate is low but there may be problems with gastroesophageal reflux |
Cost-effectiveness | Surgery is shorter and hospital stays less, so initial costs are lower, but costs for long-term nutritional management may increase | Although surgery costs are high, medical expenses may be reduced in the long term due to diabetes remission | In between |
- Citation: Shao MQ, Liao JB, Zhai MY, Wan QQ, Jiang LJ, Cui HT. Jejunoileal side-to-side anastomosis: New hope for patients with type 2 diabetes? World J Diabetes 2025; 16(5): 103447
- URL: https://www.wjgnet.com/1948-9358/full/v16/i5/103447.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i5.103447